CrEdit: CRISPR mediated multi-loci gene integration in Saccharomyces cerevisiae

Abstract

BackgroundOne of the bottlenecks in production of biochemicals and pharmaceuticals in Saccharomyces cerevisiae is stable and homogeneous expression of pathway genes. Integration of genes into the genome of the production organism is often a preferred option when compared to expression from episomal vectors. Existing approaches for achieving stable simultaneous genome integrations of multiple DNA fragments often result in relatively low integration efficiencies and furthermore rely on the use of selection markers.ResultsHere, we have developed a novel method, CrEdit (CRISPR/Cas9 mediated genome Editing), which utilizes targeted double strand breaks caused by CRISPR/Cas9 to significantly increase the efficiency of homologous integration in order to edit and manipulate genomic DNA. Using CrEdit, the efficiency and locus specificity of targeted genome integrations reach close to 100% for single gene integration using short homology arms down to 60 base pairs both with and without selection. This enables direct and cost efficient inclusion of homology arms in PCR primers. As a proof of concept, a non-native β-carotene pathway was reconstructed in S. cerevisiae by simultaneous integration of three pathway genes into individual intergenic genomic sites. Using longer homology arms, we demonstrate highly efficient and locus-specific genome integration even without selection with up to 84% correct clones for simultaneous integration of three gene expression cassettes.ConclusionsThe CrEdit approach enables fast and cost effective genome integration for engineering of S. cerevisiae. Since the choice of the targeting sites is flexible, CrEdit is a powerful tool for diverse genome engineering applications.Electronic supplementary materialThe online version of this article (doi:10.1186/s12934-015-0288-3) contains supplementary material, which is available to authorized users.

Control of metabolite efflux in microbial cell factories: current advances and future prospects

“…Of course one cannot also fail to mention the variants of CRISPR/Cas9 gene editing technology that allow almost unlimited tinkering (e.g. in yeast [309,310]). …”

CasPER, a method for directed evolution in genomic contexts using mutagenesis and CRISPR/Cas9

“…The carotenoid expressing strain was constructed as described previously (Ronda et al, 2015), herein labelled TC-100.…”

Insert, remove or replace: A highly advanced genome editing system using CRISPR/Cas9

“…Ronda [16]. Using CrEdit, the efficiency and locus specificity of targeted genome integrations reached close to 100% for single gene integration in S. cerevisiae.…”

“…Multiple additional strategies were designed using dCas9 that was deprived of the capacity to make SSB or DSB, but can efficiently bind to target sites. One of them is dCas9-Fok1 fusion, in which Fok1 nuclease domain is fused to dCas9 and this fusion protein needs to form a dimer for effective gene targeting using two sgRNA, whose sites are separated by [13][14][15][16][17][18] bp enabling Fok1 nuclease dimerization and nuclease activity [127,128]. This again helped to A C C E P T E D M A N U S C R I P T reduce non-specific DNA contacts by four additional mutations and has greatly reduced the offtarget effects to essentially non-detectable levels when tested in human cells [35].…”